To effectively support the overall scientific goals of this SPORE the investigators of the SPORE Design and Analysis Core (SPORE D&A Core) will: 1) Develop, test, implement, update and maintain (after discussing with the other Core investigators and the SPORE project investigators their particular data and statistical needs), a flexible Master Database that will allow for fast retrieval for statistical analysis of any segment of the data be it from a single project or multiple projects, that will allow for the addition of new projects or new variables in ongoing projects and that will include quality control and security features that will guarantee that the SPORE data is of high quality. 2) Collaborate with SPORE investigators to develop, test, implement and maintain the data system including all data collection, data entry, data transmission and editing procedures needed to maintain the quality, integrity and security of the data at each of the data entry sites of this distributed entry system. 3) Develop, test, produce and maintain a Manual of Operations and a Forms Manual that cover in detail all aspects of data collection and management. 4) Develop a scheduling program for the Pathology Core that will indicate what types of patients are scheduled for surgery, when and where, what types of tissue can be expected to be available and what types of tissue are needed by which SPORE investigators. 5) Develop a tracking program for the Pathology Core which will allow the Core to know exactly the deposition of any tissue or sera. 6) Develop scheduling programs, as needed, for the individual clinical trials. 7) Develop both an online system and a paper report system that keeps the SPORE investigators informed as to the demographic, clinical and pathological aspects of patients in the SPORE database. This system will also include what additional investigations are in progress or have been completed (e.g. is tissue being analyzed for p53). 8) Collaborate with the Career Development Committee to offer both informal and formal education in epidemiology (particularly with reference to design aspects) and statistics. 9) Collaborate with investigators on all aspects of a study from initial developmental discussions, to development of a formal proposal (including development of testable hypotheses, sample size considerations and plans for analysis), to the statistical analysis of the study, and finally to manuscript preparation. 10) Participate in collaborative discussions among SPORE members (led by Dr. Scardino) concerning developing questions that can be addressed using data that cuts across disciplines (e.g. integrating the demographic, clinical, pathological and clinical markers data).

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
3P50CA058204-03S2
Application #
3731472
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
3
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Baylor College of Medicine
Department
Type
DUNS #
074615394
City
Houston
State
TX
Country
United States
Zip Code
77030
Olar, Adriana; He, Dandan; Florentin, Diego et al. (2014) Biological correlates of prostate cancer perineural invasion diameter. Hum Pathol 45:1365-9
Olar, Adriana; He, Dandan; Florentin, Diego et al. (2014) Biologic correlates and significance of axonogenesis in prostate cancer. Hum Pathol 45:1358-64
Sonpavde, Guru; Wang, Mingjun; Peterson, Leif E et al. (2014) HLA-restricted NY-ESO-1 peptide immunotherapy for metastatic castration resistant prostate cancer. Invest New Drugs 32:235-242
Nakka, Manjula; Agoulnik, Irina U; Weigel, Nancy L (2013) Targeted disruption of the p160 coactivator interface of androgen receptor (AR) selectively inhibits AR activity in both androgen-dependent and castration-resistant AR-expressing prostate cancer cells. Int J Biochem Cell Biol 45:763-72
Ding, Yi; He, Dandan; Florentin, Diego et al. (2013) Semaphorin 4F as a critical regulator of neuroepithelial interactions and a biomarker of aggressive prostate cancer. Clin Cancer Res 19:6101-11
Feng, Shu; Dakhova, Olga; Creighton, Chad J et al. (2013) Endocrine fibroblast growth factor FGF19 promotes prostate cancer progression. Cancer Res 73:2551-62
Yang, Feng; Zhang, Yongyou; Ressler, Steven J et al. (2013) FGFR1 is essential for prostate cancer progression and metastasis. Cancer Res 73:3716-24
Yang, Guang; Goltsov, Alexei A; Ren, Chengzhen et al. (2012) Caveolin-1 upregulation contributes to c-Myc-induced high-grade prostatic intraepithelial neoplasia and prostate cancer. Mol Cancer Res 10:218-29
Yu, Wendong; Feng, Shu; Dakhova, Olga et al. (2011) FGFR-4 ArgĀ³?? enhances prostate cancer progression via extracellular signal-related kinase and serum response factor signaling. Clin Cancer Res 17:4355-66
Darimipourain, M; Wang, S; Ittmann, M et al. (2011) Transcriptional and post-transcriptional regulation of Sprouty1, a receptor tyrosine kinase inhibitor in prostate cancer. Prostate Cancer Prostatic Dis 14:279-85

Showing the most recent 10 out of 262 publications